Sinopharm Group Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sinopharm Group Co Ltd with three other
drug stores in Asia:
Medipal Holdings Corporation
sales of 3.15 trillion Japanese Yen [US$28.10 billion]
of which 67%
was Pharmaceuticals And Food Precessing Whol),
Shanghai Pharmaceuticals Holding Co Ltd
(159.08 billion Chinese Renmimbi [US$23.73 billion]
Alfresa Holdings Corporation
based in Japan
(2.60 trillion Japanese Yen [US$23.24 billion]
of which 87%
was Wholesale Business of Pharmaceuticals fo).
During the year ended December of 2018, sales at
Sinopharm Group Co Ltd were 344.53 billion Chinese Renmimbi (US$51.39 billion).
increase of 24.1%
versus 2017, when the company's sales were 277.72 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Sinopharm Group Co Ltd
(and since 2013, sales have increased a total of 106%).